{"title":"Urgent Necessity for Standardized and Evidence Based Plant Immunomodulators (Such As Rice Bran Arabinoxylan Concentrate/MGN-3) for the Tumor Research","authors":"T. Hajtó","doi":"10.15406/IJCAM.2017.09.00296","DOIUrl":null,"url":null,"abstract":"In the last time a case report was published that a MEK (Mitogen activated Extracellular signal regulation Kinase) inhibitors which can down regulate the receptor tyrosine kinase mediated signaling pathway [1-3] given in a combination with a standardized and evidence based plant immunomodulators was able to induce complete remissions of lung, liver and brain metastases [4]. Since these therapy modalities can’t result in similar astonishing clinical responses if they are applied separately [5] the hypothesis arouse that without standardized and evidence based plant immunomodulators the further tumor research is impeded.","PeriodicalId":92796,"journal":{"name":"International journal of complementary & alternative medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of complementary & alternative medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/IJCAM.2017.09.00296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
In the last time a case report was published that a MEK (Mitogen activated Extracellular signal regulation Kinase) inhibitors which can down regulate the receptor tyrosine kinase mediated signaling pathway [1-3] given in a combination with a standardized and evidence based plant immunomodulators was able to induce complete remissions of lung, liver and brain metastases [4]. Since these therapy modalities can’t result in similar astonishing clinical responses if they are applied separately [5] the hypothesis arouse that without standardized and evidence based plant immunomodulators the further tumor research is impeded.